Publication | Closed Access

Astragaloside IV inhibits migration and invasion in human lung cancer A549 cells via regulating PKC-α-ERK1/2-NF-κB pathway

Pkc-α-erk1/2-nf-κb PathwayCancer ResearchOncogenic AgentMedicineImmunologyCancer Cell BiologyAstragaloside IvCancer BiologyCell BiologyCell SignalingLung CancerTumor BiologyCancer Growth